| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Konstantinos Xynos is Chief Medical Officer at REPL. Konstantinos Xynos's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.6M at current prices.
Historically, Konstantinos Xynos's trades have earned a middling insider score of 54/100 across 8 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +12.2%.
The REPL filings lean toward selling, a net 78,248 shares.
Konstantinos Xynos has 15 Form 4 filings on record from December 2022 to August 2026, all as Chief Medical Officer at Replimune Group (REPL), 2022–2026.
The 20 reported transactions were 9 open-market sales, 6 stock awards and 5 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 9 sales worth about $682K.
The largest open-market sale was 11,447 shares of REPL at an average $12.97 on August 10, 2026, about $148K.
1 of the 9 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other 8 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 11,447 | $12.97 | $148,467.59 | -4.9% | - | - | |
| May 18, 2026 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 14,023 | $5.08 | $71,236.84 | -5.6% | +192.0% | - | |
| Nov 17, 2025 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,248 | $9.10 | $65,956.80 | -4.9% | -17.2% | - | |
| May 20, 2025 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,952 | $8.06 | $64,093.12 | -5.1% | -42.0% | -43.9% | |
| Nov 18, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,246 | $10.78 | $78,111.88 | -6.2% | +30.3% | -18.8% | |
| Jun 7, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell10b5-1 | 15,881 | $7.50 | $119,107.50 | -11.9% | +35.7% | +31.4% | |
| May 16, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 6,367 | $6.47 | $41,194.49 | -4.6% | +46.7% | +16.8% | |
| Nov 16, 2023 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,313 | $10.92 | $79,857.96 | -6.1% | -33.4% | +4.7% | |
| May 16, 2023 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 771 | $18.05 | $13,916.55 | -0.6% | +6.5% | -63.2% |